156 related articles for article (PubMed ID: 37667171)
1. Effect of overall lifestyle on the all-cause mortality and cardiovascular disease death in dyslipidemia patients with or without lipid-lowering therapy: a cohort study.
Wang Q; Pang D; Wang H
BMC Cardiovasc Disord; 2023 Sep; 23(1):438. PubMed ID: 37667171
[TBL] [Abstract][Full Text] [Related]
2. Combined associations of body mass index and adherence to a Mediterranean-like diet with all-cause and cardiovascular mortality: A cohort study.
Michaëlsson K; Baron JA; Byberg L; Höijer J; Larsson SC; Svennblad B; Melhus H; Wolk A; Warensjö Lemming E
PLoS Med; 2020 Sep; 17(9):e1003331. PubMed ID: 32941436
[TBL] [Abstract][Full Text] [Related]
3. The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES.
Duiyimuhan G; Maimaiti N
BMC Cardiovasc Disord; 2023 Sep; 23(1):452. PubMed ID: 37697281
[TBL] [Abstract][Full Text] [Related]
4. Effects of physical activity and sedentary behaviors on cardiovascular disease and the risk of all-cause mortality in overweight or obese middle-aged and older adults.
Zhang Y; Liu X
Front Public Health; 2024; 12():1302783. PubMed ID: 38410660
[TBL] [Abstract][Full Text] [Related]
5. Sufficient sleep duration contributes to lower cardiovascular disease risk in addition to four traditional lifestyle factors: the MORGEN study.
Hoevenaar-Blom MP; Spijkerman AM; Kromhout D; Verschuren WM
Eur J Prev Cardiol; 2014 Nov; 21(11):1367-75. PubMed ID: 23823570
[TBL] [Abstract][Full Text] [Related]
6. Association of marine PUFAs intakes with cardiovascular disease, all-cause mortality, and cardiovascular mortality in American adult male patients with dyslipidemia: the U.S. National Health and Nutrition Examination Survey, 2001 to 2016.
Tang X; Lv X; Wang R; Li X; Xu W; Wang N; Ma S; Huang H; Niu Y; Kong X
Nutr J; 2023 Oct; 22(1):48. PubMed ID: 37798712
[TBL] [Abstract][Full Text] [Related]
7. Mediating effect of depression on the association between cardiovascular disease and the risk of all-cause mortality: NHANES in 2005-2018.
Ma X; Zhang H; Tian Y; Wang Y; Liu L; Wang L
Clin Cardiol; 2023 Nov; 46(11):1380-1389. PubMed ID: 37593998
[TBL] [Abstract][Full Text] [Related]
8. Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study.
Zhu L; Hayen A; Bell KJL
Cardiovasc Diabetol; 2020 Mar; 19(1):28. PubMed ID: 32138746
[TBL] [Abstract][Full Text] [Related]
9. Association between diet-related inflammation, all-cause, all-cancer, and cardiovascular disease mortality, with special focus on prediabetics: findings from NHANES III.
Deng FE; Shivappa N; Tang Y; Mann JR; Hebert JR
Eur J Nutr; 2017 Apr; 56(3):1085-1093. PubMed ID: 26825592
[TBL] [Abstract][Full Text] [Related]
10. Effects of dietary patterns on the all-cause mortality and cardiovascular disease mortality in patients with hypertension: A cohort study based on the NHANES database.
Li F; Zhang Y; Pan L; Chen H
Clin Cardiol; 2023 Nov; 46(11):1353-1370. PubMed ID: 37587785
[TBL] [Abstract][Full Text] [Related]
11. Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012).
Georgoulis M; Chrysohoou C; Georgousopoulou E; Damigou E; Skoumas I; Pitsavos C; Panagiotakos D
Lipids Health Dis; 2022 Dec; 21(1):141. PubMed ID: 36529737
[TBL] [Abstract][Full Text] [Related]
12. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies.
Zhang YB; Chen C; Pan XF; Guo J; Li Y; Franco OH; Liu G; Pan A
BMJ; 2021 Apr; 373():n604. PubMed ID: 33853828
[TBL] [Abstract][Full Text] [Related]
13. Association of the American Heart Association's new "Life's Essential 8" with all-cause and cardiovascular disease-specific mortality: prospective cohort study.
Sun J; Li Y; Zhao M; Yu X; Zhang C; Magnussen CG; Xi B
BMC Med; 2023 Mar; 21(1):116. PubMed ID: 36978123
[TBL] [Abstract][Full Text] [Related]
14. Dyslipidemia and cardiovascular disease risk among the MASHAD study population.
Hedayatnia M; Asadi Z; Zare-Feyzabadi R; Yaghooti-Khorasani M; Ghazizadeh H; Ghaffarian-Zirak R; Nosrati-Tirkani A; Mohammadi-Bajgiran M; Rohban M; Sadabadi F; Rahimi HR; Ghalandari M; Ghaffari MS; Yousefi A; Pouresmaeili E; Besharatlou MR; Moohebati M; Ferns GA; Esmaily H; Ghayour-Mobarhan M
Lipids Health Dis; 2020 Mar; 19(1):42. PubMed ID: 32178672
[TBL] [Abstract][Full Text] [Related]
15. Association between migraine and cardiovascular disease mortality: A prospective population-based cohort study.
Liu H; Zhang S; Gong Z; Zhao W; Lin X; Liu Y; Wang S; Yu S; Dong Z
Headache; 2023 Sep; 63(8):1109-1118. PubMed ID: 37655645
[TBL] [Abstract][Full Text] [Related]
16. The importance of cardiorespiratory fitness and sleep duration in early CVD prevention: BMI, resting heart rate and questions about sleep patterns are suggested in risk assessment of young adults, 18-25 years : The cross-sectional lifestyle, biomarkers and atherosclerosis (LBA) study.
Fernström M; Fernberg U; Hurtig-Wennlöf A
BMC Public Health; 2020 Nov; 20(1):1715. PubMed ID: 33198684
[TBL] [Abstract][Full Text] [Related]
17. Association between red blood cell distribution width/albumin ratio and all-cause mortality or cardiovascular diseases mortality in patients with diabetic retinopathy: A cohort study.
Fu W; Hu F; Xu C
PLoS One; 2023; 18(12):e0296019. PubMed ID: 38128055
[TBL] [Abstract][Full Text] [Related]
18. Associations of combined lifestyle behaviors with all-cause and cardiovascular mortality in adults: A population-based cohort study in Jiangxi Province of China.
Wang T; Ding C; Zhou W; Zhu L; Yu C; Huang X; Bao H; Cheng X
Front Public Health; 2022; 10():942113. PubMed ID: 36388373
[TBL] [Abstract][Full Text] [Related]
19. Nutrition interventions for youth with dyslipidemia: a National Lipid Association clinical perspective.
Williams L; Baker-Smith CM; Bolick J; Carter J; Kirkpatrick C; Ley SL; Peterson AL; Shah AS; Sikand G; Ware AL; Wilson DP
J Clin Lipidol; 2022; 16(6):776-796. PubMed ID: 36109324
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
